Organovo CEO tells Benzinga this has the chance to be really compelling for companies who are developing drugs that have potential to be fibrotic. It is very difficult to study fibrosis due to lack of animal and in vivo models.

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!